56Indexed trials
Market Rank #40 · Evidence Tier A
Bulgaria
Neuroscience Intelligence
Bulgaria neuroscience intelligence: 56 indexed trials, 5 institutions, research score 25.67.
14Recruiting
5Research institutions
25.7Research score
Evidence profile
39Sponsors
15Disease areas
0Institution works
0Institution citations
Model signals
Opportunity 26 · ML priority 26 · Confidence 85 · Evidence 25.7
These are comparative evidence signals. They do not represent a guarantee of market size or commercial outcome.
Leading disease areas
epilepsy11trials
parkinsons6trials
multiple_sclerosis5trials
alzheimers5trials
depression4trials
schizophrenia3trials
other_psychiatry2trials
bipolar_disorder2trials
traumatic_brain_injury1trials
anxiety1trials
Leading indexed sponsors
Novo Nordisk A/S4trials
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.3trials
AbbVie3trials
Pfizer3trials
Bayer2trials
H. Lundbeck A/S2trials
Hoffmann-La Roche2trials
Boehringer Ingelheim2trials
Celgene2trials
Supernus Pharmaceuticals, Inc.2trials